Exodus Point Capital Management, LP Eli Lilly & CO Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 400 shares of LLY stock, worth $318,268. This represents 0.0% of its overall portfolio holdings.

Number of Shares

400

Previous 4,200 90.48%

Holding current value

$318,268

Previous $3.81 Million 90.7%

% of portfolio

0.0%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $10.6 Million - $13.2 Million	-13,739 Reduced 49.03%	14,285 $12.7 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $20.3 Million - $25.5 Million	28,024 New	28,024 $25.4 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $18.9 Million - $26 Million	43,388 New	43,388 $23.3 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $11.1 Million - $12.7 Million	-37,452 Reduced 43.07%	49,501 $16 Million
Q2 2022 Aug 19, 2022	BUY	$278.73 - $327.27 $24.2 Million - $28.5 Million	86,953 New	86,953 $28.2 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $6.47 Million - $8.04 Million	-27,582 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $3.75 Million - $4.66 Million	16,694 Added 153.32%	27,582 $7.62 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $2.11 Million - $2.59 Million	-9,511 Reduced 46.62%	10,888 $2.52 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $2.66 Million - $3.44 Million	-14,736 Reduced 41.94%	20,399 $4.68 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $5.77 Million - $7.47 Million	35,135 New	35,135 $6.56 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $19.1 Million - $25.3 Million	-146,672 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $16.8 Million - $19.4 Million	114,932 Added 362.1%	146,672 $21.7 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $4.33 Million - $5.21 Million	31,740 New	31,740 $5.21 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $399,501 - $434,554	-3,741 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $414,465 - $483,786	3,741 New	3,741 $414,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $234,418 - $275,928	-2,106 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $223,025 - $249,855	2,106 New	2,106 $244,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Eli Lilly & CO Transaction History